Balaji Sridhar is a CU Boulder Chemical Engineering PhD candidate halfway through two years of the Medical Scientist Training Program, a joint effort between CU campuses in Denver and Boulder.
Ten active companies have been created since 1997 based on technologies invented wholly or in part by CU chemical and biological engineering students and their faculty supervisors.
Recognizing the revenue potential of CU-licensed science moving to the commercial market, CU is looking at how to best maximize proceeds from technology transfer. The university plans to soon seek bids from consultants to help with this process.
The outstanding research conducted by the faculty and students in our department has lead to the following successful start up companies:
ALD Nanosolutions (Steven George and Al Weimer) helps customers accelerate their product innovation. ALDN's proprietary Particle ALD coating technology, which can apply designed coatings at the nanometer scale on particles of any size, creates enormous commercial opportunity for new materials development and integration. In addition, Polymer ALD forms nanocoatings on polymer films, where ALDN is developing continuous roll to roll ALD coating capability. ALDN's multi-layer ALD films will fundamentally shift commercial polymer coating processes to lower cost, higher performance films.
BaroFold Inc. (Theodore Randolph) is a company that uses high-pressure technology developed in the Randolph laboratories to dissegragate and fold therapeutic proteins to their biologically active three dimensional structure.
Ion Engineering (Doug Gin and Rich Noble) is a start-up company formed by former students and postdocs from the Noble and Gin research groups. This company focuses on using ionic liquid-amine solutions for large-scale CO2 removal from industrial combustion exhaust.
Mosaic Biosciences (Kristi Anseth and Chris Bowman): is advancing a fundamentally new class of synthetic materials to support native tissue regeneration. Mosaic expects to significantly impact the field of tissue regeneration, including applications in wound healing, bone regeneration, cartilage repair, stem cell therapy, and dermal fillers.
OPX Biotechnologies, Inc. (Ryan Gill) is a Colorado-based bioproducts company using proprietary bioengineering technology to convert renewable feedstocks into biofuels and green chemistry products. The OPX EDGE - Efficiency Directed Genome Engineering - technology platform enables rapid, rational, and robust optimization of microbes and bioprocesses. Compared to petroleum-based alternatives, OPX EDGE bioprocesses deliver equivalent product performance with improved sustainability at lower cost. Using the EDGE platform, OPX has produced multiple biofuel and green chemistry products at laboratory scale from several different renewable feedstocks. OPX is proving its economical bioprocesses at larger scale in advance of a demonstration plant startup in 2011. OPX is located in Boulder, Colorado, currently employs 40 individuals, and is funded by Altira Group LLC, Braemar Energy Ventures, MDV - Mohr Davidow Ventures and X/Seed Capital.
RxKinetix (Theodore Randolph) is a drug delivery company which was sold to Endo Pharmaceuticals.
SFC Fluidics (Rich Noble): This technology focuses on manufacturing an electrochemical pump with no moving parts. This object is useful for a number of applications of controlled delivery, including drugs.
Sundrop Fuels Inc. (Alan Weimer) is a solar gasification-based renewable energy company out of Louisville, CO.